Ticker Symbol: GTH
Genetron Holdings Ltd - ADR
$13.30 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: ADR
CIK:0001782594
Company Profile
Genetron Holdings Limited ("Genetron Health" or the "Company") is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products.
Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Standard Industrial Classification Code (SIC code): 8071
Address: N/A
Website: www.genetronhealth.com
CEO: N/A
Tags:
- Health Services
- Medical/Nursing Services
- Health Care and Social Assistance
- Medical Laboratories
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.80
Change:
$0.01
(
1.78%)
Days Range: $0.77 - $0.84
Beta: 0.19
52wk. High: $1.27
52wk. Low: $0.69
Ytd. Change -27.59%
50 Day Moving Average: $0.92
200 Day Moving Average: $0.92
Shares Outstanding: 91548706
Valuation
Market Cap: 7.4B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A